Incretin receptor agonists have been effective in combatting obesity and diabetes. While the body of knowledge regarding the signaling mechanisms of glucagon-like peptide 1 (GLP-1) receptor agonists is ever-growing, glucose-dependent insulinotropic polypeptide receptor (GIPR) agonists are less understood. The previewed papers offer insight into the impact of adipose GIPR on energy and weight homeostasis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cmet.2024.12.003 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!